深度学习启用多omics集成:精确的药物目标发现的新前沿.
Yufei Ren1, Haotian Bai1, Jihan Wang2
1School of Physics and Electronic Information, Yan'an University, Yan'an 716000, China.
Biology
|March 13, 2026
概括
深度学习 (DL) 增强了多领域的整合,以精确发现药物标,克服传统方法的局限性. 这种方法可以识别新的疾病驱动因素,并优先考虑精准医学的治疗目标.
科学领域:
- 计算生物学 计算生物学
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于复杂的疾病,制药研发面临着高昂的成本和消耗.
- 单一的omics方法难以捕捉系统性疾病的复杂性.
- 深度学习 (DL) 为药物发现提供先进的多omics集成.
研究的目的:
- 审查用于药物标发现的DL驱动的多omics集成方面的进展.
- 探索DL架构和多omics数据的集成策略.
- 检查DL在识别疾病驱动因素和治疗点方面的有效性.
主要方法:
- 在多学科集成中对DL应用进行系统审查.
- 描述多主题数据基础和整合策略.
- 探索DL架构 (例如,CNN,RNN,GNN) 用于omics数据处理.
主要成果:
- DL有效地整合了多omics数据以识别新型疾病驱动因素.
- DL有助于预测针对性治疗的合成致死性相互作用.
- DL提高了潜在治疗点的优先级.
结论:
- 由DL驱动的多omics集成是精确药物发现的强大工具.
- 解决数据稀疏性和可解释性等挑战至关重要.
- 新兴的人工智能技术 (生成性AI,LMMs,XAI) 提供了未来的机遇.
更多相关视频
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
2.2K
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
1.1K
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
61
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
61
Drug Discovery: Overview
12.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.7K
Targets for Drug Action: Overview
11.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.0K
Genomics
41.4K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
41.4K
